Health Condition 1: F30-F39- Mood [affective] disorders Health Condition 2: F20-F29- Schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders
Conditions
Interventions
Intervention1: NOT APPLICABLE: NOT APPLICABLE
Control Intervention1: Neurocognitive functioning.: Neurocognitive functioning of persons with Severe mental Illness with no metabolic syndrome will be co
Sponsors
Government Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Persons with Severe Mental Illness. Any gender. Aged between 18 and 50 years. Has adequate capacity (as per section 4 of Mental Health Care Act, 2017) to give consent.
Exclusion criteria
Exclusion criteria: Those uncooperative for assessment of metabolic syndrome and neuro-cognitive testing. Those with history of delay in developmental milestones. Those with medically diagnosable and /or self-reported and / or history of: Auditory impairment, Visual impairment(except those by uncorrected refractive errors) colour blindness. Those with co-morbid conditions like: Organic brain syndrome, Head injury,Past history of cerebrovascular accident,Epilepsy, Diagnosed medical conditions like (hypothyroidism, chronic kidney disease, heart failure and end stage carcinoma patients) and history of CABG. Those with active suicidal tendencies. Those with co-morbid substance dependence except nicotine and caffeine. Patients receiving Cognitive Enhancement Therapy, or Cognitive Behaviour Therapy in last 6 weeks. Patients receiving Electro Convulsive Therapy (ECT) in last 6 weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In accordance with previous studies, neurocognitive functioning in persons with severe mental illness and metabolic syndrome shall have deficits or deficits of higher percentiles when compared with persons having severe mental illness without metabolic syndrome.Timepoint: Baseline data will be collected. | — |
Secondary
| Measure | Time frame |
|---|---|
| Prevalence of metabolic syndrome in persons with Severe Mental Illness.Timepoint: Baseline.;The results can be used to strategize preventive measures against metabolic syndrome and plan cognitive enhancement therapies in persons with Severe Mental Illness, in addition to the treatment they are receiving. In persons with Severe Mental Illness, along with usual treatment, focus can be given to preventive interventions too, in relation to the metabolic syndrome as well as cognitive deficits (like cognitive enhancement therapy).Timepoint: Not applicable. | — |
Countries
India
Contacts
Public ContactDr Jyotsana Garg
Government Medical College and Hospital
Outcome results
None listed